- Price is above the Trend Line, keeping the weekly tape constructive.
- Volume is elevated versus the 13-week average, confirming attention.
WELL
TOR
Week ended 07 Aug 2026
Weekly Investor Report
WELL Health Technologies Corp. · Healthcare · Medical Care Facilities
Latest close
4.15 CAD
2.7%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is 0.2% above the Trend Line and sits at 22.8% of its 52-week range. The latest completed week returned 2.7%, after a -5.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100.
Setup score
35
out of 100
Latest Close
4.15 CAD
7 Aug 2026
1W Return
2.7%
latest completed week
4W Return
-5.9%
short-term follow-through
12W Return
5.1%
quarterly tape
Trend Breadth
32.7%
17 of 52 weeks active
Volume Ratio
2.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.7%
Latest completed week; four-week move -5.9%.
Indicator stack
18/38
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
2 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 0.2% above the Trend Line and sits at 22.8% of its 52-week range. The latest completed week returned 2.7%, after a -5.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4812-week average 0.35
12-week confirmation
Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.48Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -5.9% over four weeks, 5.1% over 12 weeks, and -15.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year17
Trend breadth32.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.15Latest activity-pressure read.
Pressure change-121.5%Four-week change in activity pressure.
Leadership-15.07Latest relative-leadership reading.
RS change-51.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 88%
Model confidence 82%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength71/100Blend of value, momentum, and quality. Underlying universe rank 30; rank 1 is best.
Value82/100Relative valuation strength. Underlying universe rank 19; rank 1 is best.
Quality64/100Profitability and accounting quality. Underlying universe rank 37; rank 1 is best.
Momentum11/100Medium-term price momentum. Underlying universe rank 90; rank 1 is best.
Growth87/100Revenue and earnings growth. Underlying universe rank 14; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 0.8x Market value relative to trailing revenue.
- EV / EBITDA
- 8.6x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 5.3% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 44.2% Gross profit retained from each unit of revenue.
- Operating margin
- 6.6% Operating profit retained from revenue.
- Free-cash-flow margin
- 6.7% Free cash flow generated from revenue.
- Return on invested capital
- 4.9% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 52.2% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 5/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.0% Cash dividends relative to market value.
- Buyback yield
- -5.3% Net share repurchases relative to market value.
- Shareholder yield
- -5.3% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 2.6x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 2 relevant articles.
0 positive · 2 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-31.7%Distance below the 52-week high.
13-week volatility5.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+10.5%Week of 5 Jun.
Worst week-8.4%Week of 19 Jun.
Latest week+2.7%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains6
Flat weeks0
Modest losses6
Sharp losses7
Recent vol5.5%13-week weekly-return volatility.
Base vol5.0%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew4.0% / -4.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCA Healthcare
4-week rank34 / 46
Group average0.0%
Trend breadth34.8%
Trend34.8%active weekly trend signals
MD47.8%positive activity pressure
RS23.9%positive relative leadership
Four-week leaders
IndustryCA Medical Care Facilities
4-week rank3 / 6
Group average-9.0%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD16.7%positive activity pressure
RS16.7%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape32/100
Trend, activity pressure, participation, and risk combine to a 32/100 tape read.
Indicator analysis55/100Latest 12-week confirmation: trend 9/12, activity pressure 11/12, relative leadership 0/12.
Activity pressure 0.48; No reversal markers Factors58/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 85; Small Cap Core rank 32 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 2 relevant articles.
Ardent Health (ARDT) Stock Price, News & Analysis Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 4.15 CAD | 2.7% | 4.14 CAD | 4.46 CAD | -0.15 | -15.07 | 8.2M | Off |
| 31 Jul 2026 | 4.04 CAD | 2.0% | 4.14 CAD | 4.46 CAD | 0.16 | -15.36 | 4.9M | Off |
| 24 Jul 2026 | 3.96 CAD | -5.5% | 4.14 CAD | 4.46 CAD | 0.49 | -18.04 | 6.4M | On |
| 17 Jul 2026 | 4.19 CAD | -5.0% | 4.14 CAD | 4.47 CAD | 0.74 | -13.72 | 5.1M | On |
| 10 Jul 2026 | 4.41 CAD | 2.3% | 4.13 CAD | 4.47 CAD | 0.71 | -9.95 | 5.2M | On |
| 3 Jul 2026 | 4.31 CAD | 4.4% | 4.12 CAD | 4.47 CAD | 0.67 | -12.43 | 996.3K | On |
| 26 Jun 2026 | 4.13 CAD | -1.0% | 4.11 CAD | 4.47 CAD | 0.84 | -15.85 | 1.0M | On |
| 19 Jun 2026 | 4.17 CAD | -8.4% | 4.10 CAD | 4.48 CAD | 0.98 | -15.36 | 1.3M | On |
| 12 Jun 2026 | 4.55 CAD | -6.0% | 4.09 CAD | 4.48 CAD | 1.05 | -7.88 | 814.7K | On |
| 5 Jun 2026 | 4.84 CAD | 10.5% | 4.08 CAD | 4.49 CAD | 0.86 | -0.76 | 1.6M | On |
| 29 May 2026 | 4.38 CAD | 5.0% | 4.06 CAD | 4.49 CAD | 0.78 | -11.25 | 5.9M | On |
| 22 May 2026 | 4.17 CAD | 5.6% | 4.09 CAD | 4.49 CAD | 0.67 | -15.13 | 6.0M | Off |
| 15 May 2026 | 3.95 CAD | -4.8% | 4.13 CAD | 4.49 CAD | 0.69 | -18.48 | 6.3M | Off |
| 8 May 2026 | 4.15 CAD | -2.8% | 4.16 CAD | 4.50 CAD | 0.74 | -15.47 | 10.2M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.